Read More Pharma Industry News Lupin secures US FDA tentative approval for generic version of Slynd contraceptive tablets Lupin wins US FDA tentative approval for generic drospirenone contraceptive, targeting a $141M US market. See how this move fits its women’s health strategy. byPallavi MadhirajuNovember 4, 2022